BRIEF published on 06/26/2024 at 07:35, 1 year 5 months ago Crossject souligne le potentiel de ZEPIZURE® à la suite des études RAMPART et de bioéquivalence Crossject ZEPIZURE® Midazolam Étude RAMPART Crises Épileptiques
BRIEF published on 06/26/2024 at 07:35, 1 year 5 months ago Crossject highlights the potential of ZEPIZURE® following RAMPART and bioequivalence studies Crossject ZEPIZURE® Midazolam RAMPART Study Epileptic Seizures
BRIEF published on 06/26/2024 at 07:20, 1 year 5 months ago METAVISIO - THOMSON : Ventes records et expansion en Asie Innovation Expansion Inde Metavisio THOMSON
BRIEF published on 06/26/2024 at 07:20, 1 year 5 months ago METAVISIO - THOMSON: Record sales and expansion in Asia Innovation Expansion India Metavisio THOMSON
BRIEF published on 06/26/2024 at 07:15, 1 year 5 months ago FINOS Welcomes Seven Financial Services and Technology Leaders, Accelerating AI, Cloud and Interoperability Strategic Initiatives Cloud Computing Interoperability AI Financial Services FINOS
BRIEF published on 06/26/2024 at 07:15, 1 year 5 months ago FINOS accueille sept leaders des services financiers et de la technologie, accélérant les initiatives stratégiques en matière d'IA, de cloud et d'interopérabilité Cloud Computing Interopérabilité Services Financiers IA FINOS
BRIEF published on 06/26/2024 at 07:10, 1 year 5 months ago ENCAVIS AG secures EUR 300 million revolving credit facility to finance its Accelerated Growth Strategy 2027 Financing Encavis AG Revolving Credit Facility Wind And Solar Energy Accelerated Growth
BRIEF published on 06/26/2024 at 07:10, 1 year 5 months ago ENCAVIS AG obtient une facilité de crédit renouvelable de 300 millions d'euros pour financer sa stratégie de croissance accélérée 2027 Financement Encavis AG Facilité De Crédit Renouvelable Énergie Éolienne Et Solaire Croissance Accélérée
BRIEF published on 06/26/2024 at 07:06, 1 year 5 months ago BioMérieux Receives FDA Clearance and CLIA-Waiver for BIOFIRE® SPOTFIRE® R/ST Panel Mini BioMérieux FDA Clearance BIOFIRE® SPOTFIRE® CLIA-waiver PCR Test
BRIEF published on 06/26/2024 at 07:06, 1 year 5 months ago BioMérieux obtient l'autorisation pour le test BIOFIRE® SPOTFIRE® R/ST Panel Mini BioMérieux BIOFIRE SPOTFIRE 510(k) CLIA Point Of Care
Published on 12/15/2025 at 15:00, 1 hour 34 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 1 hour 34 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 2 hours 4 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 2 hours 34 minutes ago Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 3 hours 4 minutes ago Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors
Published on 12/15/2025 at 16:08, 25 minutes ago Conversion of The Platform Group AG into a KGaA completed as planned
Published on 12/15/2025 at 15:50, 43 minutes ago Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 44 minutes ago Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 15:45, 48 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/15/2025 at 15:44, 49 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/15/2025 at 14:26, 2 hours 7 minutes ago 251215 BENETEAU Transactions sur actions propres
Published on 12/15/2025 at 11:50, 4 hours 43 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 30 novembre 2025
Published on 12/15/2025 at 11:50, 4 hours 43 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 22 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 18:00, 2 days 22 hours ago Déclaration des transactions sur actions propres réalisées du 24 novembre au 28 novembre 2025
